chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart arrhythmia; Symptoms of pox ever since I got that vaccine; Was experiencing numbness throughout my left side; shortly had chest pain; This spontaneous case was reported by a patient and describes the occurrence of ARRHYTHMIA (Heart arrhythmia) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARRHYTHMIA (Heart arrhythmia) (seriousness criterion medically significant), IMMUNISATION REACTION (Symptoms of pox ever since I got that vaccine), HYPOAESTHESIA (Was experiencing numbness throughout my left side) and CHEST PAIN (shortly had chest pain). At the time of the report, ARRHYTHMIA (Heart arrhythmia), HYPOAESTHESIA (Was experiencing numbness throughout my left side) and CHEST PAIN (shortly had chest pain) outcome was unknown and IMMUNISATION REACTION (Symptoms of pox ever since I got that vaccine) had not resolved.            Concomitant medications were not reported.  The patient truly 100 percent believed that patient was injured by the vaccine.  No treatment information was provided by the reporter.  Company Comment: This is a Spontaneous case concerning a patient of unknown age and gender, with no medical history reported, who experienced the unexpected and serious (due to medically significant) AESI of Arrhythmia, which occurred on an unknown date after mRNA-1273 vaccine, administered as second dose within COVID-19 vaccination schedule. Since no vaccination dates were provided, temporal association and latency cannot be properly assessed. Patient also experienced chest pain, numbness throughout left side and symptoms of pox ever since the vaccine. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.; Sender's Comments: This is a Spontaneous case concerning a patient of unknown age and gender, with no medical history reported, who experienced the unexpected and serious (due to medically significant) AESI of Arrhythmia, which occurred on an unknown date after mRNA-1273 vaccine, administered as second dose within COVID-19 vaccination schedule. Since no vaccination dates were provided, temporal association and latency cannot be properly assessed. Patient also experienced chest pain, numbness throughout left side and symptoms of pox ever since the vaccine. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.
Patient received pfizer vaccine on 02/11/21 and 03/4/21. COVID positive on 12/27/21 and hospitalized 12/28/21. She had changes in mental status, shortness of breath, and UTI.  Noted to have COVID pneumonia in addition to a UTI.  She does appear altered, unclear of baseline mental status.  CXR reviewed.  Remains on RA.  Hemodynamically stable.  Receiving IVFs and IV abx in the ED which will be continued.  To be admitted for further evaluation and management. received doxycycline and ceftriaxone. Discharged on 1/5/22
Open 24 hours of receiving the vaccine, the patient was noted to be fatigued and increasingly confused.  Had some response to IV fluids but within 72 hours became progressively hypertensive and transferred to hospital
patient spoke to DL concerning pain in her arm continuing, even though the shot was 26 days ago
After vaccination at 10:45 am, patient began to feel lightheaded and fainted for less than a minute. When patient came to, she vomited and fell out of consciousness again for about 1 minute. Upon awakening, patient vomited once again but stayed conscious and in the waiting area until EMT and ambulance arrived to check on the patient. After EMT checked the patient, they gave patient the ok to go home.
Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Arrhythmia.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 173/84 (High) 173/84 mmHg. On an unknown date, Heart rate: abnormal (abnormal) heartbeat was irregular.         Concomitant medications included Antihypertensive pills were reported.  Treatment information was not provided. The Blood Pressure unit showed heartbeat was irregular the day after both the shots.   This case was linked to MOD-2021-380699 (Patient Link).   Reporter did not allow further contact
After vaccine on 11-8-07 including Comvax lot 0376U, red welt developed seen 11-12-07, low grade fever, seen again on 11-16-07. (Later found at risk of B. cereus) Red welt, resolved, but inconsolable crying all night for 6 wks, slowly improving now, by 12-24-07. 1/8/08-information received-the injection site reaction was on right thigh.
This case was reported by a consumer via call center representative and described the occurrence of skin warm in a 80-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included fibromyalgia and shingles (5 years before the date of reporting). Concurrent medical conditions included post herpetic neuralgia. On 8th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 8th February 2019, less than a week after receiving SHINGRIX, the patient experienced feeling unwell. On 9th February 2019, the patient experienced skin warm, erythema of extremities, swelling arm and blister. In February 2019, the patient experienced influenza-like symptoms, weakness, gastric disorder and injection site coloration. On an unknown date, the patient experienced neuropathic pain. On an unknown date, the outcome of the skin warm, erythema of extremities, swelling arm, feeling unwell, influenza-like symptoms, weakness, gastric disorder, blister, injection site coloration and neuropathic pain were not recovered/not resolved. It was unknown if the reporter considered the skin warm, erythema of extremities, swelling arm, feeling unwell, influenza-like symptoms, weakness, gastric disorder, blister, injection site coloration and neuropathic pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. The patient experienced the entire upper part of her arm, just below the injection site had redness, swelling, and warmth in the area. She also noted other symptoms that had not resolved at the date of reporting. The patient's husband was a physician and he stated that the redness appeared to be red patches, oval and almost a pre blister state but noted it was not shingles. Less than a week after receiving SHINGRIX, the patient experienced flu like symptoms, stomach problems and weakness. On 13th February 2018, the patient called back and stated she had been seen by her dermatologist, who said it was not shingles but that the patient was having a reaction to the SHINGRIX vaccine. The reporter also noted she had black and blue at the site of the injection, she had pain like her neuropathy in her face, feet and back. The patient also noted she just had not felt right since receiving SHINGRIX last Friday.
pt recvd vax 2MAR93 & had severe pain in both shoulders & rt groin; end of JUN the pain was in both shoulders & both hips; stiffness; shoulders were frozen; dx spondyle arthritis;
No additional adverse effects reported; improperly store PNEUMOVAX 23 was administered to a patient; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 18-DEC-2019, the patient was vaccinated with improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) subcutaneously, lot # S017430, expiration date 18-MAY-2020 (dose and frequency were not reported) for prophylaxis. No additional adverse effects reported. The temperature excursion was 30.78 degrees Fahrenheit (F) for 15 minutes. Previously, vaccine experienced temperature excursion with the lowest temperature below 36 F (30.78 F) 311 cycles. Data logger was not involved.  This is one of two reports received from the same reporter (cross-linked with MARRS# 2001USA005259).; Sender's Comments:  US-009507513-2001USA005259:
Felt flu like symptoms on day 7 after vaccine.  Chills, body aches, headache  Noticed a large raised red patch at injection site on day 9
Symptoms of Henoch-Schönlein purpura approx. 3 days after vaccination including dark reddish splotches on the feet, legs, belly, and butt, pain and swelling in hands and feet, and abdominal pain. Symptoms worsened over the following week. Diagnosis of HSP confirmed 1 week after vaccination.
Later that day my arm at the injection site got really sore,  I applied an ice pack and by bedtime the pain was gone.   In Late August in the evening I began feeling really bad.  I slept off and on for the next week with my temp going up and down, but it never went over 100.9.   I got tired real quick and just was not feeling well so after about a week and  on 8/19 I reached out to my PCP who ordered me take a COVID test and it came back positive.  My PCP  then prescribed antibiotics, steroids and albuterol to help with the symptoms
woke up the day after shot to pain that feels like a serious sprain. I figured it would go away , but it only got worse. After a  couple months i went to my doctor. Tried predniszone which helped while i was on it but pain came back after off two days. after xray showed it was not arthritic condition went to shoulder specialist whogave a shot in shoulder which slightly improved it for about 10 days but then back to i guess i have lost 50% use of my shoulder , mabey forever.
12/2/13 vaccine administered. 12/4/13 itching, swollen arm. Noticed this morning redness around vaccination site approximately 3 inches in diameter.
Patient had severe hives one day after receiving vaccine. Seen at our office by provider for hives. Still persisted by today, 3/29/21. Severe itching and rash.
1.) Headaches 2.) Nausea 3.) Tingling sensation equivalent to when your hand/arm etc falls asleep in both my legs and the left side of my face.  4.) Occasional feeling of being short of breath - noticeable when I speak for an extended period.   The tingling sensation lasted less than 24 hours. Nausea and headaches persisted for the better part of a week (5 days roughly). The feeling of being short of breath still happens now and again, but I only really notice it if I am speaking for a prolonged period.
Vomiting the same day PCV, DTaP and HiB were given. Phenergan supp 1/4 gid and Tylenol.
Headaches. Mild to severe. Almost passed put while trying to lift weights. Extreme sensitivity to light at times. Loss of appetite.
Hives appeared on neck and chest a couple of hours after receiving the vaccine. They were gone the following day. A mild headache came on about the same time as the hives and lasted three days. Mild intermittent dizziness also occurred for a couple of hours starting when the other symptoms occurred.  Left arm was very sore and continues to have some pain five days after the injection. Decreased appetite started three days after receiving the vaccine. Today, woke up with mild sore throat, elevated temperature (current 99.4 and typically close to 97) .
Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
The day after my first vaccine dose (3/20/2021), my menstrual cycle started and I had large globs.  Some looked like large blood clots, while others looks like they might contain tissue almost like what you would expect in the event of a miscarriage.  I know for certain I was not having a miscarriage.  No treatment.  Symptoms subsided until next menstrual cycle on (3/17/2021), when I again experienced the same symptoms.  Symptoms the second time were not as prevalent as the first time but still noticeable.
Pt c/o hot flashes, fever/chills, "shakes" after vaccine given. Fell out of bed multiple times. C/o headache, body aches, involuntary muscle twitching the following AM after the vaccine given. Pt's sx resolving with 2 liters of IV fluids. 7/13/06 Received ER medical records which reveal patient experienced fever, twitching & HA since receiving MCA.  Labs were drawn & received 2L of IVF w/K+.  7/18/06 Received medical records from PCP which reveal patient experienced HA, body aches w/leg twitching & nausea but felt much better after receiving IVF at ER but HA had returned.  Initial BC + for staphylococcus lugdunensis which was felt to be skin contaminant. Dx probable adverse reaction to MCA, improving/ss
Case number PHEH2013US019556, is an initial spontaneous report received from a nurse on 16 Sep 2013, with a follow-up received on 25 Oct 2013. This report refers to a 15-year-old female patient. She received only Men A lyophilized conjugate component of MENVEO (batch number: M12104/4434AA) reconstituted with sterile water intramuscularly at a dose of 0.5 ml into left deltoid on 13 Sep 2013. She did not receive the Men C, Y, W-135 liquid conjugate component of MENVEO. Patient had no adverse event following medication error. Follow-up was received on 25 Oct 2013: Patient demographics, vaccination site, batch number and information that no adverse event was experienced were updated.
Acute metabolic encephalopathy. Patient found to have indices concerning for severe sepsis with no source of infection found. Patient empirically treated with Vanco and Merrem. Confusion cleared. Patient slightly improved and back to her baseline functional status. ED visit to hospital admission within 6 weeks of receiving the COVID-19 vaccine.
Child went down for nap day of event. Child had been acting and feeling fine all week and all day leading up to event. Child woke up from nap with fever of 104, 2 minutes after waking, child experiences an 8 minute febrile seizure.
flu like symptoms; had a deep pain in her left armpit; tingling in her left pinky finger that went numb as well as her ring finger; 'tingling in her left pinky finger that went numb as well as her ring finger; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Left arm on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient experienced flu like symptoms, deep pain in her left armpit and tingling in her left pinky finger that went numb as well as her ring finger. The outcome of all events was unknown.       No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Felt itching at shot site immediately following shot.  Over the next few hours, developed brain fog, fatigue, and headache.  About 12 hours after shot, developed extreme neuralgia from head to toe.  Entire body felt like it was being tortured with needles and fire, it was excruciating.  The neuralgia improved slightly with advil, but was still extremely uncomfortable.  It lasted about 20 hours.  Injection site pain started around 8 hours after shot and lasted three days.  Spinal headache lasted 4 days.  Chronic fatigue lasted through day three.  As of today (day 5), patient still has mild fatigue.
Case previously recorded as MA2009-4569. Case report received from an office manager via physician, via MedCom, on 12 NOV 2009. 1-year-old female patient was vaccinated with 0.25 mL of S-OIV FLUVIRIN  (batch no. 102045P1) i.m. into right thigh in 10 NOV 2009. No adverse effect was reported. MedCom reference no.: NA09-008038.
I was having diarrhea that was very urgent and sudden. At first, I did not think too much of this but this lasted for a few weeks. By the second and third week I was having bad stomach cramping and pain with tenderness when you would touch my abdomen. I reached out to my health care provider on March 2nd and they took Stool samples which checked for parasites and bacteria which all came back negative. They then sent me to the gastroenterologist on March 14th. I was starting to get better at this point but I had a cold at the end of this and was having fevers with that cold. The Gastroenterologist thought that because of that I likely had virus as I was feeling better after the cold and the fever. They did put me on fiber and a probiotic.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 03/18/21 JohnsonLot#1805031 Diagnosed covid positive:08/06/21 Symptom onset: Exposure:Travel Symptoms:
vasovagal syncope, stomach churning;felt dizzy laid back on tx table turned pale, passed out few seconds & twitching of face muscles;woke up crying but oriented;BP 130/85 HR 88;
Patient was given Dtap when he should have had Td per someone at the health dept. Patient did not have any reaction.
Received pneumoccal vaccine in right deltoid 10/25/2002 about 10:30am. Apprx.  at 3:30pm ,she experienced severe pain in her right arm extending down to her fingers to the point she could not use her arm. She was taken Tylenol- Ibuprofen- applied moist heat. On 10/28/2002 when she reported it, pain had improved somewhat although she still had significant pain from her deltoid muscle to her elbow with limited use of her arm. No numbness or tingling. No bruising or redness at the sight. No fever. Gradually improved over a two week period.
Patient came in to the pharmacy  to pick up her prescription  and told me that she had been experiencing shoulder pain especially when she lifted her arm at an angle.
Fatigue, nausea, fever (103.2).  Treated with Advil and rest.  Symptoms moderated with this but not eliminated.
The same day of vax, the pt experienced crankiness and Tylenol was given. The pt was fretful during the night. The next day the pt experienced a fever and was treated with Tylenol. No further information or complaints.
Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 18-Oct-2021; dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 18-Oct-2021) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 18-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 18-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was infection control manager.  Concomitant medication of the patient was not reported.  There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-491837 (Patient Link).
Janssen COVID-19 Vaccine EUA When I went to bed, I had chills that lasted until I fell asleep. I woke up around 3AM, I no longer had chills, but I had a migraine that lasted about an hour until I fell back asleep. When I woke up I'm the morning, I still had a slight headache.